| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
REGULAR ARTICLES |


*
University of Utah, Salt Lake City, Utah.
National Institutes of Health, Bethesda, Maryland.
University of Illinois, Chicago, Illinois.
§
University of California, Davis, Sacramento, California.
||
Davies Medical Center, San Francisco, California.
¶
Data Coordinating Center, Cleveland, Ohio.
#
Beth Israel Medical Center, New York, New York.
**
National Institute of Diabetes and Digestive and Kidney Diseases, National
Institutes of Health, Bethesda, Maryland.
Correspondence to Dr. Gerald J. Beck, HEMO Study Data Coordinating Center, Department of Biostatistics and Epidemiology, Wb4, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, Ohio 44195. Phone: 216-444-9927; Fax: 216-445-2781; E-mail: gbeck{at}bio.ri.ccf.org
Abstract. Although dialyzer reuse in chronic hemodialysis patients is commonly practiced in the United States, performance of reused dialyzers has not been extensively and critically evaluated. The present study analyzes data extracted from a multicenter clinical trial (the HEMO Study) and examines the effect of reuse on urea and ß2-microglobulin (ß2M) clearance by low-flux and high-flux dialyzers reprocessed with various germicides. The dialyzers evaluated contained either modified cellulosic or polysulfone membranes, whereas the germicides examined included peroxyacetic acid/acetic acid/hydrogen peroxide combination (Renalin®), bleach in conjunction with formaldehyde, glutaraldehyde or Renalin, and heated citric acid. Clearance of ß2M decreased, remained unchanged, or increased substantially with reuse, depending on both the membrane material and the reprocessing technique. In contrast, urea clearance decreased only slightly (approximately 1 to 2% per 10 reuses), albeit statistically significantly with reuse, regardless of the porosity of the membrane and reprocessing method. Inasmuch as patient survival in the chronic hemodialysis population is influenced by clearances of small solutes and middle molecules, precise knowledge of the membrane material and reprocessing technique is important for the prescription of hemodialysis in centers practicing reuse.
This article has been cited by other articles:
![]() |
A. K. Cheung, T. Greene, J. K. Leypoldt, G. Yan, M. Allon, J. Delmez, A. S. Levey, N. W. Levin, M. V. Rocco, G. Schulman, et al. Association between Serum 2-Microglobulin Level and Infectious Mortality in Hemodialysis Patients Clin. J. Am. Soc. Nephrol., January 1, 2008; 3(1): 69 - 77. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Upadhyay, M. A. Sosa, and B. L. Jaber Single-Use versus Reusable Dialyzers: The Known Unknowns Clin. J. Am. Soc. Nephrol., September 1, 2007; 2(5): 1079 - 1086. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ouseph, S. Jones, N. Dhananjaya, and R. A. Ward Use of ultrafiltered dialysate is associated with improvements in haemodialysis-associated morbidity in patients treated with reused dialysers Nephrol. Dial. Transplant., August 1, 2007; 22(8): 2269 - 2275. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Cheung, M. V. Rocco, G. Yan, J. K. Leypoldt, N. W. Levin, T. Greene, L. Agodoa, J. Bailey, G. J. Beck, W. Clark, et al. Serum beta-2 Microglobulin Levels Predict Mortality in Dialysis Patients: Results of the HEMO Study J. Am. Soc. Nephrol., February 1, 2006; 17(2): 546 - 555. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. G. Lowrie, Z. Li, N. Ofsthun, and J. M. Lazarus Reprocessing dialysers for multiple uses: recent analysis of death risks for patients Nephrol. Dial. Transplant., November 1, 2004; 19(11): 2823 - 2830. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Collins, J. Liu, and J. P. Ebben Dialyser reuse-associated mortality and hospitalization risk in incident Medicare haemodialysis patients, 1998-1999 Nephrol. Dial. Transplant., May 1, 2004; 19(5): 1245 - 1251. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Cheung, N. W. Levin, T. Greene, L. Agodoa, J. Bailey, G. Beck, W. Clark, A. S. Levey, J. K. Leypoldt, D. B. Ornt, et al. Effects of High-Flux Hemodialysis on Clinical Outcomes: Results of the HEMO Study J. Am. Soc. Nephrol., December 1, 2003; 14(12): 3251 - 3263. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Locatelli Dose of dialysis, convection and haemodialysis patients outcome--what the HEMO study doesn't tell us: the European viewpoint Nephrol. Dial. Transplant., June 1, 2003; 18(6): 1061 - 1065. [Full Text] [PDF] |
||||
![]() |
G. Eknoyan, G. J. Beck, A. K. Cheung, J. T. Daugirdas, T. Greene, J. W. Kusek, M. Allon, J. Bailey, J. A. Delmez, T. A. Depner, et al. Effect of Dialysis Dose and Membrane Flux in Maintenance Hemodialysis N. Engl. J. Med., December 19, 2002; 347(25): 2010 - 2019. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Vinhas and J. P. d. Santos Haemodialyser reuse: facts and fiction Nephrol. Dial. Transplant., January 1, 2000; 15(1): 5 - 8. [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673